M3, Inc. (TYO: 2413)
Japan
· Delayed Price · Currency is JPY 1,391.50
-2.50 (-0.18%)
Jan 20, 2025, 3:30 PM JST
M3, Inc. Revenue
M3, Inc. had revenue of 60.61B JPY in the quarter ending September 30, 2024, with 3.79% growth. This brings the company's revenue in the last twelve months to 247.91B, up 5.94% year-over-year. In the fiscal year ending March 31, 2024, M3, Inc. had annual revenue of 238.88B with 3.49% growth.
Revenue (ttm)
247.91B
Revenue Growth
+5.94%
P/S Ratio
3.81
Revenue / Employee
20.49M
Employees
12,100
Market Cap
944.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 238.88B | 8.07B | 3.49% |
| Mar 31, 2023 | 230.82B | 22.66B | 10.89% |
| Mar 31, 2022 | 208.16B | 38.96B | 23.03% |
| Mar 31, 2021 | 169.20B | 38.23B | 29.19% |
| Mar 31, 2020 | 130.97B | 17.91B | 15.84% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| HOYA Corporation | 812.74B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Terumo | 986.67B |
| Otsuka Holdings | 2,269.56B |
| Astellas Pharma | 1,772.16B |
| Olympus | 973.60B |